药学服务对COPD患者吸入剂使用和认知度影响

Effects of Pharmaceutical Services on Inhalant Use and Awareness in COPD Patients

目的分析对于住院治疗的慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)患者采取药学服务对于提高其吸入剂使用技术以及认知程度的作用效果。方法 2018年1—6月诊治的COPD患者120例随机分组为观察组、对照组。对照组患者治疗期间仅采取常规的用药指导,观察组患者则采取药学服务干预,对比两组患者吸入剂使用技术以及疾病认知程度。结果两组患者干预之前关于吸入剂使用技术的评分均较低;干预后观察组患者的评分改善效果较对照组更优(P <0.05);两组患者干预之前关于COPD疾病认知程度评分均较低;干预后观察组患者对于COPD疾病认知程度评分上升幅度较对照组明显更高(P <0.05)。结论对于住院治疗的COPD患者采取药学服务干预,有助于提高患者对吸入剂应用技术的掌握程度,可提升患者的疾病认知程度。

Objective To analyze the effect of taking pharmaceutical services for hospitalized patients with chronic obstructive pulmonary disease(COPD)on improving their inhalant use technology and cognitive level.Methods From January to June 2018,120 patients with COPD were randomly divided into observation group and control group.Patients in the control group only received conventional medication guidance during the treatment,while patients in the observation group received pharmaceutical service intervention.Inhalant use technology and disease awareness of patients in the two groups were compared.Results Before intervention,patients in both groups had a low score on the use of inhalant.After intervention,the improvement effect of scores in the observation group was better than that in the control group(P<0.05).Before intervention,the cognitive scores of patients with COPD were both low.After intervention,the cognitive score of patients in the observation group for COPD disease increased significantly more than that in the control group(P<0.05).Conclusion Pharmaceutical care intervention for hospitalized COPD patients is helpful to improve the patients’mastery of inhalant application technology,and to improve the patients’disease awareness.